Potential Efficacy of Nutrient Supplements for Treatment or Prevention of COVID-19

被引:13
|
作者
Bogan-Brown, Katrina [1 ]
Nkrumah-Elie, Yasmeen [2 ]
Ishtiaq, Yusrah [3 ]
Redpath, Philip [2 ]
Shao, Andrew [3 ]
机构
[1] Brownian Consulting LLC, Hanover, NH USA
[2] ChromaDex Inc, Longmont, CO USA
[3] ChromaDex Inc, 10900 Wilshire Blvd,Ste 600, Los Angeles, CA 90024 USA
关键词
Autoimmune; coronavirus; COVID-19; nicotinamide adenine dinucleotide; oxidative stress; SARS-CoV-2; vitamin B3; vitamin C; vitamin D; zinc;
D O I
10.1080/19390211.2021.1881686
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
COVID-19 (COronaVIrus Disease of 2019), the disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), represents an ongoing global health challenge and the deadliest epidemic coronavirus outbreak to date. Early sequencing of the viral genome and knowledge from past coronavirus outbreaks (SARS-CoV-1 and Middle East Respiratory Syndrome, MERS) has led to rapid advances in knowledge of how the virus spreads and infects human hosts. Unfortunately, advancing knowledge has not yet produced a treatment that substantially lowers morbidity or mortality and only recently resulted in the development of a vaccine that prevents severe disease. Mounting evidence supports the notion that dietary supplementation of key essential nutrients may contribute to the body's defenses against infection as well as bolster the body's responses to infection. Evidence supporting the potential beneficial roles of vitamin C, vitamin D, zinc, and B3 vitamins is reviewed here, revealing a combination of basic research elucidating underlying mechanisms of action, preclinical studies and human intervention studies has led to the proliferation of registered clinical trials on COVID-19. Overall, the data suggest this collection of nutrients has a promising impact on reducing the risk and/or severity of COVID-19, although firm conclusions await the results of these trials.
引用
收藏
页码:336 / 365
页数:30
相关论文
共 50 条
  • [31] Potential treatment of COVID-19
    Ayten, Omer
    Ozdemir, Cengiz
    Akturk, Ulku Aka
    Sen, Nazan
    EURASIAN JOURNAL OF PULMONOLOGY, 2020, 22 (04) : 35 - 44
  • [32] Sitagliptin: a potential drug for the treatment of COVID-19?
    Bardaweel, Sanaa K.
    Hajjo, Rima
    Sabbah, Dima A.
    ACTA PHARMACEUTICA, 2021, 71 (02) : 175 - 184
  • [33] Could nutritional supplements act as therapeutic adjuvants in COVID-19?
    Giorgio Costagliola
    Erika Spada
    Pasquale Comberiati
    Diego G. Peroni
    Italian Journal of Pediatrics, 47
  • [34] Could nutritional supplements act as therapeutic adjuvants in COVID-19?
    Costagliola, Giorgio
    Spada, Erika
    Comberiati, Pasquale
    Peroni, Diego G.
    ITALIAN JOURNAL OF PEDIATRICS, 2021, 47 (01)
  • [35] Bovine colostrum and its potential contributions for treatment and prevention of COVID-19
    Duman, Hatice
    Karav, Sercan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Are Nutraceuticals Effective in COVID-19 and Post-COVID Prevention and Treatment?
    Catalano, Alessia
    Iacopetta, Domenico
    Ceramella, Jessica
    De Maio, Azzurra Chiara
    Basile, Giovanna
    Giuzio, Federica
    Bonomo, Maria Grazia
    Aquaro, Stefano
    Walsh, Thomas J.
    Sinicropi, Maria Stefania
    Saturnino, Carmela
    Geronikaki, Athina
    Salzano, Giovanni
    FOODS, 2022, 11 (18)
  • [37] Vitamin C and D Supplements to Prevent the Risk of COVID-19
    Shahrajabian, Mohamad Hesam
    Cheng, Qi
    Sun, Wenli
    NATURAL PRODUCTS JOURNAL, 2023, 13 (01)
  • [38] Three novel prevention, diagnostic, and treatment options for COVID-19 urgently necessitating controlled randomized trials
    Horowitz, Richard, I
    Freeman, Phyllis R.
    MEDICAL HYPOTHESES, 2020, 143
  • [39] Potential Benefits of Tryptophan Metabolism to the Efficacy of Tocilizumab in COVID-19
    Belladonna, Maria Laura
    Orabona, Ciriana
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [40] Hydroxychloroquine and chloroquine: a potential and controversial treatment for COVID-19
    Zou, Li
    Dai, Lijun
    Zhang, Xingyu
    Zhang, Zhaohui
    Zhang, Zhentao
    ARCHIVES OF PHARMACAL RESEARCH, 2020, 43 (08) : 765 - 772